A Biopsy-based 17-gene Genomic Prostate Score as a Predictor of Metastases and Prostate Cancer Death in Surgically Treated Men with Clinically Localized Disease
- 1 January 2018
- journal article
- research article
- Published by Elsevier BV in European Urology
- Vol. 73 (1), 129-138
- https://doi.org/10.1016/j.eururo.2017.09.013
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Prognostic Utility of the Cell Cycle Progression Score Generated from Biopsy in Men Treated with ProstatectomyJournal of Urology, 2014
- Analytical validation of the Oncotype DX prostate cancer assay – a clinical RT-PCR assay optimized for prostate needle biopsiesBMC Genomics, 2013
- Radical Prostatectomy versus Observation for Localized Prostate CancerNew England Journal of Medicine, 2012
- Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective studyThe Lancet Oncology, 2011
- Use of Archived Specimens in Evaluation of Prognostic and Predictive BiomarkersJNCI Journal of the National Cancer Institute, 2009
- Weighted analyses for cohort sampling designsLifetime Data Analysis, 2008
- Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)JNCI Journal of the National Cancer Institute, 2005
- Martingale-based residuals for survival modelsBiometrika, 1990
- Martingale-Based Residuals for Survival ModelsBiometrika, 1990
- Partial residuals for the proportional hazards regression modelBiometrika, 1982